SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from Avalo Therapeutics, Inc. (AVTX) (CIK 0001534120) (AVTX) — Dec 5, 2016

Avalo Therapeutics, Inc. (AVTX) (CIK 0001534120)
Date: Dec. 5, 2016 · CIK: 0001534120 · Accession: 0001558370-16-010391

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-214507

Date
December 5, 2016
Author
Not clearly detected
Form
CORRESP
Company
Avalo Therapeutics, Inc. (AVTX) (CIK 0001534120)

Letter

cerc_Current_Folio_CORRESP_Comment_Letter

December 5, 2016

Via EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Mail Stop 4546

Washington, D.C. 20549

Attn:

Suzanne Hayes

Scot Foley

Mary Beth Breslin

Re:

Cerecor Inc.

Registration Statement on Form S-3

File No. 333-214507

Acceleration Request

Requested Date: Wednesday, December 7, 2016

Requested Time: 4:30 P.M. Eastern Standard Time

Ladies and Gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-214507) (the “Registration Statement”) to become effective on Wednesday, December 7, 2016, at 4:30 p.m. Eastern Standard Time, or as soon thereafter as is practicable, or at such later time as the Registrant may orally request via telephone call to the staff (the “Staff”).

Once the Registration Statement has been declared effective, please orally confirm that event with Brent B. Siler of Cooley LLP, counsel to the Registrant, at (202) 728-7040, or in his absence, Madison Jones at (202) 728-7087.

[Signature page follows]

Very truly yours,
Cerecor Inc.

Show Raw Text
CORRESP
1
filename1.htm

			cerc_Current_Folio_CORRESP_Comment_Letter

			December 5, 2016

			Via EDGAR

						U.S. Securities and Exchange Commission

						Division of Corporation Finance

						100 F Street, N.E.

						Mail Stop 4546

						Washington, D.C. 20549

						Attn:

						Suzanne Hayes

						Scot Foley

						Mary Beth Breslin

						Re:

						Cerecor Inc.

						Registration Statement on Form S-3

						File No. 333-214507

						Acceleration Request

						Requested Date:  Wednesday, December 7, 2016

						Requested Time:  4:30 P.M. Eastern Standard Time

			Ladies and Gentlemen:

			In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-214507) (the “Registration Statement”) to become effective on Wednesday, December 7, 2016, at 4:30 p.m. Eastern Standard Time, or as soon thereafter as is practicable, or at such later time as the Registrant may orally request via telephone call to the staff (the “Staff”).

			Once the Registration Statement has been declared effective, please orally confirm that event with Brent B. Siler of Cooley LLP, counsel to the Registrant, at (202) 728-7040, or in his absence, Madison Jones at (202) 728-7087.

			[Signature page follows]

						Very truly yours,

						Cerecor Inc.

						By:

						/s/ Mariam E. Morris

						Mariam E. Morris

						Chief Financial Officer

						cc:

						Uli Hacksell, Ph.D., Cerecor Inc.

						Brent B. Siler, Cooley LLP

			Cooley LLP   1299 Pennsylvania Avenue, NW, Suite 700   Washington, DC   20004-2400

			t: (202) 842-7800  f: (202) 842-7899  cooley.com